Borrelia burgdorferi p30 - IgG Marker: A Critical Indicator for Lyme Disease Diagnosis
The Borrelia burgdorferi p30 - IgG marker is an antibody test used to detect exposure to Borrelia burgdorferi, the bacterium responsible for Lyme disease. This specific marker targets the p30 protein, a key antigen expressed by Borrelia burgdorferi. The presence of IgG antibodies against the p30 protein indicates that the body has encountered the bacteria, typically during an active or past infection.
What Does an Elevated p30 - IgG Marker Indicate?
An elevated Borrelia burgdorferi p30 - IgG result suggests that the individual has been exposed to Borrelia burgdorferi and has developed an immune response, producing IgG antibodies. These antibodies typically indicate a past or chronic infection, as IgG is the antibody type associated with long-term immunity or immune memory.
Unlike some other Lyme disease markers, the p30 protein is highly specific to Borrelia burgdorferi, making it a useful tool in confirming a Lyme disease diagnosis. Elevated levels of Borrelia burgdorferi p30 - IgG may indicate the presence of a persistent or chronic infection, as IgG antibodies are often detectable after the initial acute phase of Lyme disease, even if symptoms are not currently active.
The Role of the p30 Protein in Lyme Disease
The p30 protein is an integral part of the bacterium’s outer structure, contributing to its ability to invade and persist within the body. Because this protein is unique to Borrelia burgdorferi, detecting antibodies against it provides a strong indication of Lyme disease exposure. The p30 - IgG test is often used in conjunction with other Lyme disease tests to provide a comprehensive assessment of the infection.
Importance of the p30 - IgG Marker in Lyme Disease Testing
The Borrelia burgdorferi p30 - IgG marker is particularly useful in cases where other Lyme disease markers, like VlsE1, may not provide clear results. Since p30 is specific to Borrelia burgdorferi, it can help confirm the diagnosis, especially in cases of chronic or late-stage Lyme disease. Elevated p30 - IgG levels, when considered alongside clinical symptoms and other diagnostic tests, can help healthcare providers determine whether Lyme disease is contributing to a patient’s health concerns.
Conclusion
The Borrelia burgdorferi p30 - IgG marker is an important diagnostic tool for identifying exposure to Borrelia burgdorferi, the bacterium responsible for Lyme disease. Elevated levels of IgG antibodies against the p30 protein suggest a past or chronic infection, providing valuable insight into the presence of Lyme disease. If you have elevated test results for p30 - IgG, it’s essential to consult a healthcare provider for further evaluation and appropriate treatment to address the potential effects of Lyme disease.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.